SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-19-020750
Filing Date
2019-01-29
Accepted
2019-01-29 16:02:05
Documents
3
Period of Report
2019-01-25
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K d700236d8k.htm 8-K 18398
2 EX-99.1 d700236dex991.htm EX-99.1 13691
3 GRAPHIC g700236g0129085716832.jpg GRAPHIC 4748
  Complete submission text file 0001193125-19-020750.txt   40221
Mailing Address 480 PLEASANT STREET SUITE B300 WATERTOWN MA 02472
Business Address 480 PLEASANT STREET SUITE B300 WATERTOWN MA 02472 617-926-5000
EyePoint Pharmaceuticals, Inc. (Filer) CIK: 0001314102 (see all company filings)

IRS No.: 262774444 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-51122 | Film No.: 19548718
SIC: 3826 Laboratory Analytical Instruments
Assistant Director 10